Urine CXCL10 Chemokine Monitoring Post-renal Transplant

See also
Status	Clinical Trial	Phase
Completed	`NCT02581436` - Testing Immunosuppression Threshold in Renal Allografts To Extend eGFR	N/A
Active, not recruiting	`NCT02409940` - To Elucidate the Effect of Mesenchymal Stem Cells on the T Cell Repertoire of the Kidney Transplant Patients	Phase 1
Completed	`NCT02377193` - Simulect Versus ATG in Sensitized Renal Transplant Patient	Phase 4
Completed	`NCT00771745` - Prospective Pilot Study of Pre-Transplant Thymoglobulin Administration in Living Donor Renal Transplant Recipients	Phase 4
Not yet recruiting	`NCT05385432` - Induction in Sensitized Kidney Transplant Recipients Without Pre-existing Donor-specific antiboDies	Phase 3
Completed	`NCT01953120` - Mechanisms of Belatacept Effect on Alloimmunity and Antiviral Response After Kidney Transplantation (BMS IM 103-309)	Phase 4
Terminated	`NCT01324934` - Efficacy and Safety of ATG-Fresenius Following a Renal Transplantation, Without Corticosteroids	Phase 3
Terminated	`NCT00983645` - A Trial Comparing Prograf and Neoral Use in Kidney Transplant Recipients of Hispanic Ethnicity	Phase 4
Active, not recruiting	`NCT04530630` - Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide After Renal Transplant	Phase 4
Recruiting	`NCT03707262` - Study of Combined Kidney and Blood Stem Cell Transplant From a Brother or Sister Donor	Phase 1/Phase 2
Completed	`NCT02006108` - Imaging Kidney Transplant Rejection Using Ferumoxytol-Enhanced Magnetic Resonance	N/A
Recruiting	`NCT03991780` - Fostamatinib in the Treatment of Chronic Active Antibody Mediated Rejection	Phase 1/Phase 2
Completed	`NCT02733029` - Contrast Enhanced Ultrasonography to Detect Human Renal Transplant Rejection	Phase 2
Active, not recruiting	`NCT02057965` - Mesenchymal Stromal Cell Therapy in Renal Recipients	Phase 2
Completed	`NCT00658073` - Induction Therapy With Autologous Mesenchymal Stem Cells for Kidney Allografts	N/A
Terminated	`NCT03646344` - Heme Arginate in Transplantation Study	Phase 3
Completed	`NCT02866682` - Prospective Study Comparing Brand and Generic Immunosuppression on Transplant Outcomes, Adherence, & Immune Response in Kidney Transplant Recipients	Phase 4
Completed	`NCT02500251` - Belimumab Impacting Transplant Eligibility	Phase 1/Phase 2
Completed	`NCT00866879` - Randomized Conversion of Calcineurin-Inhibitors in Renal Allograft Recipients	Phase 4
Active, not recruiting	`NCT03511560` - Envarsus on the Effect of Total Tacrolimus Dose/Trough Level Ratio on Renal Function (eGFR) in Kidney Transplantation	Phase 4

NCT number	NCT03140514
Study type	Interventional
Source	University Hospital, Basel, Switzerland
Contact
Status	Completed
Phase	N/A
Start date	September 28, 2017
Completion date	July 15, 2022

Urine CXCL10 Chemokine Monitoring Post-renal Transplant

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms